GMP Expansion - Accelerated Build
What the buyer wrote
In order to deliver the Contracting Authorities advanced therapies experimental medicine programme there is a requirement for construction of a new adeno-associated virus (AAV) viral vector GMP manufacturing unit and a new cell therapy unit to allow the manufacture of additional and broader range of cell therapy products, including embryonic stem cell derived products.
Details
- What the buyer calls it
- GMP Expansion - Accelerated Build
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- works
- Where
- in London
- Kind of work
- New build construction
Who the buyer named
Andrew Fowler was the named contact on this notice.